“Deucravacitinib Long-Term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s48. Accessed April 25, 2026. https://skin.dermsquared.com/skin/article/view/1803.